ArticleOncology letters2013
Sorafenib combined with gemcitabine in EGFR-TKI-resistant human lung cancer cells.
Jing Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleOncology letters2013
Jing Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.